Company Overview
Snapshot
Founded in February 2021, RNAway operates with 1–10 employees and has secured funding across one round from Copia Agro & Food. The company is developing a patented platform technology for RNA molecule delivery into plants, leveraging nanotechnology, drug delivery, and gene therapy expertise.
Business overview
RNAway is an Agriculture & Food Technologies company that develops and markets a patented platform technology designed to deliver RNA molecules into plants via spray or irrigation. This technology is based on groundbreaking research in nanotechnology, drug delivery, and gene therapy, offering a novel approach for various agricultural applications. The company serves crop protection companies, providing them with proof-of-concepts to further develop into commercialized products within the Ag Tech sector, specifically focusing on Genetics & Input.
Log in to access full profile ›Company Intelligence Q&A
- When was RNAway founded?
- RNAway was founded in February 2021.
- What is RNAway's primary focus?
- RNAway focuses on developing and marketing a patented platform technology for delivering RNA molecules into plants for various agricultural applications.
- What kind of technology does RNAway utilize?
- RNAway's technology leverages nanotechnology, drug delivery, and gene therapy expertise to enable RNA molecule delivery into plants.
- Which sector does RNAway operate in?
- RNAway operates in the Agriculture & Food Technologies sector, specifically within Ag Tech and Genetics & Input.
- Who is a disclosed investor in RNAway?
- In January 2022, RNAway received funding from Copia Agro & Food.